Therapeutic Methods and Pancreatic Cancer Stem Cells
changes, including as mutations of the WNT, K-RAS, TP53, Hedgehog, transforming growth factor-, and NOTCH signaling pathways (90% of cases). Given that cancer stem cells play a significant role
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
changes, including as mutations of the WNT, K-RAS, TP53, Hedgehog, transforming growth factor-, and NOTCH signaling pathways (90% of cases). Given that cancer stem cells play a significant role
cell activation inhibitor 1 and prognosis, clinic pathological features, tumor mutational burden, microsatellite instability, methyl transferase, mismatch repair, immune cell permeation among different tumors…
responsible for perceiving colors. When the genes responsible for these photo pigments are mutated, color vision is altered. In some cases, color blindness can be acquired later in life ... This can result from diseases…
identify the driver genes which are dysregulated in non-small cell lung cancer (NSCLC). Also, we identified the mutations in the form of single nucleotide polymorphisms (SNPs
precision medicine has revolutionized pediatric cancer treatment. Targeted therapies, tailored to the specific genetic mutations driving a child’s cancer, have shown remarkable efficacy in certain cases. This approach…
progression of lung cancer, encompassing non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). By dissecting the key drivers of tumor initiation, metastasis, and treatment resistance, this ... involves a…
approach leverages the analysis of various components in bodily fluids to detect genetic mutations, circulating tumor cells (CTCs), cell-free DNA (cfDNA), and other biomarkers associated with cancer. In this
cells. Overexpression of NAF-1 enhanced antioxidant capacity and oxidative stress resistance, increasing tumor volume 3-fold. In contrast, a stabilizing mutation in NAF-1 inhibited cluster transfer to recipient…
tumor components, such as cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes, from blood or other bodily fluids. These biomarkers provide valuable information about…
balance between cell proliferation and death, unleashing uncontrolled cell growth. These alterations can arise from various influencing factors, including genetic mutations, exposure to carcinogens, viral infections…
further research and characterization. Mitochondria are responsible for generating adenosine triphosphate the cell's primary energy currency. Mutations in mitochondrial DNA can disrupt this process, leading to various…
Philadelphia-negative chronic Myeloproliferative Neoplasms (MPNs) are characterised by the prevalence of somatic mutation JAK2V617F and associated with a high Cardiovascular Disease (CVD) burden, including ischemic…
Lymphocytic Leukemia (CLL) rely on pathway inhibitors targeting Bruton Tyrosine Kinase (BTK) or B Cell Lymphoma 2 (BCL2), while the use of Chemo Immunotherapy (CIT) is limited to contexts where ... C481S and C481R and…
critical components of the cellular machinery that regulates cell growth and prevents the development of cancer. Inactivation or mutation of these genes is a hallmark of many cancer types
identification of novel functionally damaging mutations in 6 genes from 13 ovarian cancer cell lines. The mutations identified were further validated with the wet lab experiments. For the first time
mutation of prothrombin gene. Electrophysiological studies showed both axonal and demyelinating patterns. Brain and spinal cord contrast enhanced MRI was normal. Peripheral blood immunophenotyping showed a lymph…
vitro. Cancer is one of the most challenging illnesses, designated by the expansion of mutated cells that proliferate and spread to different organs uncontrollably. The traditional therapeutic strategies used
For authors and organisers
Find the right journal for your paper and submit your manuscript.